BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT02684370 · COMPLETED
Trial details
- NCT number
- NCT02684370
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-12-01
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.